New eggs

New eggs

256 Cb'~rFNT TOHCS Eight charts showing these effects are included in an article reporting the work ("Degradation of Cotton Fibers and Yarns by Heat...

77KB Sizes 2 Downloads 108 Views

256

Cb'~rFNT TOHCS

Eight charts showing these effects are included in an article reporting the work ("Degradation of Cotton Fibers and Yarns by Heat and Moisture," in May Textile Research Journal, by R. S. Orr, L. C. Weiss, G. C. Humphreys, T. Mares, and J. N. Grant). A reprint may be obtained by writing the Southern Regional Research Laboratory, 2100 Robert E. Lee Boulevard, New Orleans, La. N e w E g g s . - - C u r r e n t l y , the N a v y is testing two egg products which may mean that better eggs will soon be used by the fleet. The first is a "thermostabilized shell egg" which is expected to have 60 per cent longer storage life than the oil-dipped eggs now used. The second of the egg products is dried eggs treated with a special enzyme or baker's yeast removing the glucose which breaks down over a period of time producing an offflavor. Strontium-90 Self Luminous M a r k e r s . - - E v a l u a t i o n tests at the Naval Research Laboratory have shown safer, brighter, and longer lasting self-luminous markers may now be made for military equipment and personnel in a variety of colors. Instead of radium, the new markers use strontium-90 as the radioactive material to produce luminescence. The use of strontium-90 permits markers to be made in a variety of colors throughout the visible spectrum, with the possible exception of deep red, in contrast with the limited yellowish-green of radium. The "life" of a radioactive material is measured in terms of its half-life, or time required for its radioactivity to decay to half the original value; the. half life of strontium-90 is 25 years, making possible markers with many years of useful life. There is also less radiation hazard from markers using strontium-90 than from those in which radium is used.

[J. F. I.

N e w Antihistamine for Acute AIlergies.--Parke, Davis & Company (Detroit) has announced a new form of Ambodryl Hydrochloride, an antihistamine for treating a wide variety of allergies including hay fever, allergic rhinitis, asthma, urticaria, eczema and migraine. It is Steri-Vial Ambodryl Hydrochloride, an aqueous solution for parenteral use in acute allergic states "calling for immediate relief of an extremely distressed patient." Each cubic centimeter of the new drug contains 5 mg. Ambodryl Hydrochloride (bromodiphenhydramine hydrochloride), and physicians may inject the solution, as supplied in Steri-Vials, intravenously or intramuscularly. Parke-Davis said intravenous injection of the antihistamine is preferred and results in rapid action when needed for relief of an acute allergic state. The company also explained that Ambodryl solution is valuable for the patient not responding quickly enough to oral forms of antihistamines. Dosage of the Ambodryl solution depends on the type of allergic state being treated and its severity. Usual adult dosage is 1 to 2 cc. (5 to 10 rag.) intravenously. "This dosage may be repeated in three hours, if needed, although usually doses are given once or twice daily," the company pointed out. Single doses as high as 10 cc. have been given without toxic effects, ParkeDavis noted. However, a total daily divided dosage not to exceed 10 cc. (50 rag.) is recommended. Steri-Vial Ambodryl Hydrochloride is supplied as individual 10-co. rubber diaphragm-capped vials containing 5 mg. Ambodryl Hydrochloride per co. in aqueous diluent. Parke-Davis also supplies the antihistamine in capsule and elixir forms.